β₂-Agonist abuse in food producing animals: use of in vitro liver preparations to assess biotransformation and potential target residues for surveillance

References

• BIANCOTTO, G., ANGELETTI, R., PIRO, R. D. M., FAVRETTO, D. and TRALDI, P., 1997, Ion trap high-performance liquid chromatography/multiple mass spectrometry in the determination of beta-agonists in bovine urines. Journal of Mass Spectrometry, 32, 781–784.
   Google Scholar
• BOPPANA, V. K., LYNN, R. A. and ZIEMNIAK, J. A., 1989, Immobilized sulphatase : beta-glucuronidase enzymes for the qualitative and quantitative analysis of drug conjugates. journal of Pharmaceutical Sciences, 127, 127–131.
   Google Scholar
• CHEN, T. H., Kusums, B. I. and BRASELTON, W. E., 1989, Hydroxylation of 4,4'-methylenebis-(2-chloroaniline) by canine, guinea-pig, and rat liver microsomes. Drug Metabolism and Disposition, 17, 406–413.
   PubMedGoogle Scholar
• COLDHAM, N. G., MOORE, A. S., DAVE, M., GRAHAM, P. J., SIVAPATHASUNDARA M, S., LAICE, B. G. and SAUER, M. J., 1995, Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity. Drug Metabolism and Disposition, 23, 501–505.
   PubMed Web of Science ®Google Scholar
• CONOLLY, M. E., DAVIES, D. S., DOLLERY, C. T., MORGAN, C. D., PATERSON, J. W. and SANDLER, M., 1972, Metabolism of isoprenaline in dog and man. British Journal of Pharmacology, 46, 458–472
   PubMed Web of Science ®Google Scholar
• CONWAY, W. D., SINGHVI, S. M., GIBALDI, M. and BOYES, R. N., 1973, The effect of route of administration on the metabolic fate of terbutaline in the rat. Xenobiotka, 3, 813–821.
   PubMed Web of Science ®Google Scholar
• CONWAY, W. D., MINATOYA, H., LANDS, A. M. and SHEKOSKY, J. M., 1968, Absorption and elimination profile of isoproteranol III. Journal of Pharmaceutical Sciences, 57, 1135–1141.
   PubMed Web of Science ®Google Scholar
• DAVIES, D. S., GEORGE, C. F., BLACKWELL, E., CONOLLY, M. E. and DOLLERY, C. T., 1974, Metabolism of terbutaline in man and dog. British Journal of Clinical Pharmacology, 1, 129–136.
   PubMedGoogle Scholar
• DENGLER, H. J. and HENGSTMANN, J. H., 1976, Metabolism and pharmacokinetics of orciprenaline in various animal species and man. Archives Internationales de Pharmacodynamie et de Therapie, 233, 71–87.
   Google Scholar
• GEORGE, C. F., 1981, Drug metabolism by the gastrointestinal mucosa. Clinical Pharmacokinetks, 6, 259–274.
   PubMed Web of Science ®Google Scholar
• GUENTERT, T. W., BUSKIN, J. A. and GALEAZZI, R. L., 1984, Single dose pharmacokinetics of mabuterol in man. Arzneimittel-Forschung/Drug Research, 34, 1691–1696.
   PubMedGoogle Scholar
• GUPTA, R. and DAM, H. M., 1989, In vitro formation of organ-specific ultimate carcinogens of 4- dimethylaminoazobenzene and urethane by microsomes. Toxicology Letters, 45, 49–53. HOOGENBOOM, L. A. P., 1991, The use of pig hepatocytes for biotransformation and toxicity studies. PhD thesis, RIKILT, Wageningen.
   Google Scholar
• HOOGENBOOM, L. A. P., HESSE, S. E., BERGHMANS, M. C. J. and KINPER, H. A., 1990, The use of primary culture of pig hepatocytes for biotransformation studies of veterinary drugs. In F. Simon, P. Lees and G. Senijen (eds), Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals (Hungary: University of Veterinary Science), pp 467–479.
   Google Scholar
• HORIBA, M., MURAI, T., NOMURA, K., YUGE, T., SANTA, K. and OSADA, E., 1984, Pharmacokinetic studies of mabuterol, a new selective /32-stimulant. II: Urinary metabolites of mabuterol in rats and their pharmacological effects. Arzneimittel -Forschung /Drug Research, 34, 1668–1679.
   PubMedGoogle Scholar
• KECK, J., KRUGER, G., NoLL, K. and MACHLEIDT, H., 1972, Synthesen von neuen amino-halogen-substituierten phenyl-aminoathanolen. Arzneimittel -Forschung /Drug Research, 22, 861–869.
   PubMed Web of Science ®Google Scholar
• KOPITAR, Z., ZIMMER, A., BINDER, B., FOLDENNAUER, K., HEINTZ, V., KASCHICE, S. and SCHMAUS, H., 1976, Pharmakokinetik und Metabolitenmuster von Clenbuterol bei der Ratte. Arzneimittel-Forschung /Drug Research, 26, 1435–1441.
   PubMed Web of Science ®Google Scholar
• KOSTER, A. S., ANK, C. FRANKHUIJZEN -SIEREVOGEL, A. C. and NOORDHOEK, J., 1985, Glucuronidation of morphine and six beta, sympathomimetics in isolated rat intestinal epithelial cells. Drug Metabolism and Disposition, 13, 232–238.
   Google Scholar
• LAKE, B. G., 1987, Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism. In K. Snell and B. Mullock (eds), Biochemical Toxicology (Oxford: IRL Press), pp. 183–209.
   Google Scholar
• LAKE, B. G., SAUER, M. J., ESCLANGON, F., BEAMAND J. A., PRICE, R. J. and WALTERS, D. G., 1995, Metabolism of coumarin by precision-cut calf liver slices and calf liver microsomes. Xenobiotka, 25, 133–141.
   Google Scholar
• MANCHEE, G. R., BARROW, A., KULKARNI, S., PALMER, E., OXFORD, J., COLTHUP, P. V., MACONOCHIE J. G. and TARBIT, M. H., 1993, Disposition of salmeterol xinafoate in laboratory animals and humans. Drug Metabolism and Disposition, 21, 1022–1028.
   Google Scholar
• MARTIN, L. E., HOBSON, J. C., PAGE, J. A. and HARRISON, C., 1971, Metabolic studies of salbutamo1-3H: a new bronchodilator, in rat, rabbit, dog. European. Journal of Pharmacology, 14, 183-199. MARTINEZ -NAVARRO, J. F., 1990, Food poisoning related to consumption of illicit /3-agonist in liver. Lancet, 336, 1311.
   Google Scholar
• MENNES, W. C., BLAAUBOER, B. J. and VAN HOLSTEUN, C. W. M., 1988, Biotransformation and cytotoxicity studies in primary hepatocyte cultures derived from different mammalian species. In A. Guillouzo (ed.), Liver Cells and Drugs. Colloque INSERM, vol. 164 (London: Libby), pp. 351–355.
   Google Scholar
• MORGAN, D. C., SANDLER, M., DAVIES, D. S., CONOLLY, M., PATERSON, J. W. and DOLLERY, C. T., 1969, The metabolic fate of DL-(7-3H) isoprenaline in man and dog. Proceedings of the Biochemical Society, 494th Meeting, p. 8.
   Google Scholar
• MORGAN, D. J., 1990, Clinical pharmacokinetics of /3-agonist. Clinical Pharmacokinetics, 18, 270-294. PARRISH, A. R., GANDOLPHI, A. J. and BRENDEL, K., 1995, Precision-cut tissue slices: Applications in pharmacology and toxicology. Life Sciences, 57, 1887–1901.
   Google Scholar
• PERSSON, K. and PERSSON, K., 1972, The metabolism of terbutaline in vivo by rat and human 0-methyltransferases and monoamine oxidases. Xenobiotka, 2, 375–382.
   PubMed Web of Science ®Google Scholar
• PooL, B. L., BRENDLER, S. Y., LlEGIBEL, U. M., TOMPA, A. and SCHMEZER, P., 1990, Employment of adult mammalian primary cells in toxicology: in vivo and in vitro genotoxic effects of environmentally significant N-nitroso-dialkylamines in cells of the liver, lung and kidney. Environmental and Molecular Mutagens, 5, 24–35.
   Google Scholar
• PULCE, C., LAMAISON, D., KECK, G., BOSTVIRONNOIS, C., NICOLAS, J. and DESCOTES, J., 1991, Collective human poisonings by clenbuterol residues in veal liver. Veterinary and Human Toxicology, 33, 480–481.
   PubMedGoogle Scholar
• ROMINGER, K. L. and POLLMANN W., 1972, Vergleichende Pharmakokinetik von Fenoterol-Hydro-bormid bei Ratte Hund und Mensch. Arzneimittel-Forschung/Drug Research, 22, 1190–1196.
   Google Scholar
• SALLERAS, L., DOMINGUEZ, A., MATA, E., TABERNER, J. L., MORO, I. and SALVA, P., 1995, Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Report, 110, 338–342.
   PubMed Web of Science ®Google Scholar
• SAUER, M. J., PICKETT, R. J. H., LrmER, S. and DIXON, S. N., 1995, Distribution and elimination of clenbuterol in tissues and fluids of calves following prolonged oral administration at a growth-promoting dose. Journal of Veterinary Pharmacology and Therapeutics, 18, 81–86.
   Google Scholar
• SCHMID, J., PROX, A., ZIMMER, A., KECK, J. and KASCHKE, S., 1990, Biotransformation of clenbuterol. Fresenius Journal of Analytical Chemistry, 337, 121.
   Google Scholar
• SHIMIZU, T., MORI, H., TABUSA, E., MORITA, S., MIYAMOTO, G., YASUDA, Y. and NAKAGAWA, K., 1978, The metabolism of a bronchodilator procaterol. HC1 in the rat in vitro and in vivo. Xenobiotka, 8, 349–358.
   PubMed Web of Science ®Google Scholar
• SHuLL, L. R., KIRSCH, D. G., LOHSE, C. K., CARLSON, G. P., DODDY, L. K. and WrsNrEwsm, J. A., 1986, Xenobiotic metabolism in suspensions and primary cultures of isolated hepatocytes prepared from the caudate process of the bovine liver. American Journal of Veterinary Research, 47, 2043–2052.
   PubMedGoogle Scholar
• SUOLINNA, E.-M. and WINBERG, A.-M., 1985,7-Ethoxycoumarin-O-deethylation and methyl-umbel-liferone conjugation in isolated fetal and adult bovine hepatocytes. Drug Metabolism and Disposition, 13, 722–724.
   PubMedGoogle Scholar
• TANABE, H., KAGEYAMA, H., KUBO, J. and NARUCHI, T., 1984, Metabolic fate of clenbuterol (NAB 365) (III). Metabolism in rats and dogs. Iyakuhin Kenkyu, 15, 467–476.
   Google Scholar
• YAMAMOTO, I., IWATA, K. and NAKASHEVIA M., 1985, Pharmacokinetics of plasma and urine clenbuterol in man, rat and rabbit. Journal of Pharmacobiodynamics, 8, 385–391.
   Google Scholar
• ZALCO, D., DEBRALTWER, L., BORIES, G. and TULL1EZ, J., 1997, Evidence for a new major metabolic pathway of clenbuterol involving in vivo formation of an N-hydroxylarylamine. Chemical and Research Toxicology, 10, 197–204.
   Google Scholar
• ZIMMER, A. and BUCHELER, A., 1976, Einmalapplikation, Mehrfachapplikation und Metabolitenmuster von Clenbuterol beim Menschen. Arzneimittel Forschung /Drug Research, 26, 1446–1450.
   PubMedGoogle Scholar
• ZIMMER, A., BUCHELER, A. and KASCHKE, S., 1976, Pharmakokinetik und Metabolitenmuster von Clenbuterol beim Kaninchen und beim Hund. Arzneimittel Forschung /Drug Research, 26, 1442–1445.
   PubMed Web of Science ®Google Scholar